Nneka N Ufere1, Jennifer L Halford2, Joshua Caldwell2, Min Young Jang2, Sunil Bhatt3, John Donlan4, Janet Ho5, Vicki Jackson5, Raymond T Chung4, Areej El-Jawahri3. 1. Liver Center and Gastrointestinal Division, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA. Electronic address: nufere@partners.org. 2. Harvard Medical School, Boston, Massachusetts, USA. 3. Division of Hematology and Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA. 4. Liver Center and Gastrointestinal Division, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA. 5. Division of Palliative Care and Geriatric Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Abstract
CONTEXT: Patients with decompensated cirrhosis have high rates of health care utilization at end of life (EOL). However, the impact of transplant candidacy on intensity of EOL care is currently unknown. OBJECTIVES: To assess the relationship between transplant candidacy and intensity of EOL care in the last year of life in an ambulatory cohort of patients with decompensated cirrhosis. METHODS: We performed a retrospective analysis of 230 patients with decompensated cirrhosis who were evaluated for liver transplantation in a large health care system between 1/1/2010 and 12/31/2017 and died by 6/20/2018. We compared health care utilization in the last year of life and EOL care outcomes between transplant-listed (n = 133) and nonlisted (n = 97) patients. We examined predictors of palliative and hospice care utilization using multivariate logistic regression. RESULTS: During the last year of life, patients had a median of three hospitalizations (IQR 2-5) and spent a median of 31 days (IQR 16-49) in the hospital. In all, 80% of patients died in the hospital, with 70% dying in the intensive care unit. The majority (70.0%) received a life-sustaining procedure (mechanical ventilation, renal replacement therapy, or cardiopulmonary resuscitation) during their terminal hospitalization, which did not differ between transplant-listed and nonlisted patients (74.4% vs. 63.9%, P = 0.09). Transplant-listed patients had lower odds of receiving specialty palliative care (odds ratio 0.43, P = 0.005). Patients with hepatocellular carcinoma had higher odds of receiving hospice care (odds ratio 2.03, P = 0.049). CONCLUSION: Patients with decompensated cirrhosis had intensive health care utilization during their last year of life regardless of transplant candidacy. Further work is needed to optimize their EOL care, particularly for patients who are ineligible for transplantation.
CONTEXT: Patients with decompensated cirrhosis have high rates of health care utilization at end of life (EOL). However, the impact of transplant candidacy on intensity of EOL care is currently unknown. OBJECTIVES: To assess the relationship between transplant candidacy and intensity of EOL care in the last year of life in an ambulatory cohort of patients with decompensated cirrhosis. METHODS: We performed a retrospective analysis of 230 patients with decompensated cirrhosis who were evaluated for liver transplantation in a large health care system between 1/1/2010 and 12/31/2017 and died by 6/20/2018. We compared health care utilization in the last year of life and EOL care outcomes between transplant-listed (n = 133) and nonlisted (n = 97) patients. We examined predictors of palliative and hospice care utilization using multivariate logistic regression. RESULTS: During the last year of life, patients had a median of three hospitalizations (IQR 2-5) and spent a median of 31 days (IQR 16-49) in the hospital. In all, 80% of patientsdied in the hospital, with 70% dying in the intensive care unit. The majority (70.0%) received a life-sustaining procedure (mechanical ventilation, renal replacement therapy, or cardiopulmonary resuscitation) during their terminal hospitalization, which did not differ between transplant-listed and nonlisted patients (74.4% vs. 63.9%, P = 0.09). Transplant-listed patients had lower odds of receiving specialty palliative care (odds ratio 0.43, P = 0.005). Patients with hepatocellular carcinoma had higher odds of receiving hospice care (odds ratio 2.03, P = 0.049). CONCLUSION:Patients with decompensated cirrhosis had intensive health care utilization during their last year of life regardless of transplant candidacy. Further work is needed to optimize their EOL care, particularly for patients who are ineligible for transplantation.
Authors: W R Kim; J R Lake; J M Smith; D P Schladt; M A Skeans; S M Noreen; A M Robinson; E Miller; J J Snyder; A K Israni; B L Kasiske Journal: Am J Transplant Date: 2019-02 Impact factor: 8.086
Authors: Jody C Olson; Julia A Wendon; David J Kramer; Vicente Arroyo; Rajiv Jalan; Guadalupe Garcia-Tsao; Patrick S Kamath Journal: Hepatology Date: 2011-11 Impact factor: 17.425
Authors: Sandhya K Mudumbi; Claire E Bourgeois; Nicholas A Hoppman; Catherine H Smith; Manisha Verma; Marie A Bakitas; Cynthia J Brown; Alayne D Markland Journal: J Palliat Med Date: 2018-04-26 Impact factor: 2.947
Authors: Arpan A Patel; Anne M Walling; Joni Ricks-Oddie; Folasade P May; Sammy Saab; Neil Wenger Journal: Clin Gastroenterol Hepatol Date: 2017-02-04 Impact factor: 13.576
Authors: Catherine R Butler; Peter P Reese; James D Perkins; Yoshio N Hall; J Randall Curtis; Manjula Kurella Tamura; Ann M O'Hare Journal: J Am Soc Nephrol Date: 2020-09-09 Impact factor: 10.121
Authors: Christopher D Woodrell; Nathan E Goldstein; Jaison R Moreno; Thomas D Schiano; Myron E Schwartz; Melissa M Garrido Journal: J Pain Symptom Manage Date: 2020-10-06 Impact factor: 3.612
Authors: Naoka Murakami; Nathan D Baggett; Margaret L Schwarze; Keren Ladin; Andrew M Courtwright; Hilary J Goldberg; Eric P Nolley; Nelia Jain; Michael Landzberg; Kirsten Wentlandt; Jennifer C Lai; Myrick C Shinall; Nneka N Ufere; Christopher A Jones; Joshua R Lakin Journal: J Palliat Med Date: 2022-03-11 Impact factor: 2.947